Home › Kanser sa Pancreas › Virginia › Arlington
Pag-aaral pangklinika para sa Kanser sa Pancreas sa Arlington, VA
Isang pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Study of PHN-012 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- PHN-012-001 Site, Fairfax · 11 mi ang layo
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 3
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Nagre-recruitPhase 3
- Investigative Site US057, Fairfax · 11 mi ang layo
- Investigative Site US065, Fairfax · 11 mi ang layo
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Nagre-recruitPhase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi ang layo
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi ang layo
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Nagre-recruitPhase 1
- NEXT - Virginia, Fairfax · 11 mi ang layo
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology, Fairfax · 11 mi ang layo
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Nagre-recruitObservasyonal na pag-aaral
- Inova Fairfax Hospital, Falls Church · 4 mi ang layo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Nagre-recruitPhase 2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Nagre-recruitPhase 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Nagre-recruitPhase 3
- Inova Fairfax Hospital, Falls Church · 4 mi ang layo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Pancreatic Cancer Early Detection Consortium
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- NEXT Virginia, Fairfax · 11 mi ang layo
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Nagre-recruitPhase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi ang layo
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Nagre-recruitPhase 1
- Research Site, Fairfax · 11 mi ang layo
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Nagre-recruitPhase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
- Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Next Oncology Virginia, Fairfax · 11 mi ang layo
A 2-part Phase 1/2 Open-label Trial on ODM-212
Nagre-recruitPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi ang layo
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Nagre-recruitPhase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi ang layo
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- NEXT Virginia, Fairfax · 11 mi ang layo
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Nagre-recruitPhase 1/2
- NEXT, Virginia, Fairfax · 11 mi ang layo
Pag-aaral para sa Kanser sa Pancreas sa ibang lungsod
- Houston, TX61 pag-aaral
- New York City, NY60 pag-aaral
- Boston, MA43 pag-aaral
- Nashville, TN39 pag-aaral
- Los Angeles, CA35 pag-aaral
- St. Louis, MO33 pag-aaral
- Baltimore, MD31 pag-aaral
- San Antonio, TX31 pag-aaral
- Philadelphia, PA26 pag-aaral
- Tampa, FL26 pag-aaral
- Durham, NC24 pag-aaral
- San Diego, CA24 pag-aaral
Iba pang pag-aaral sa Arlington
- Non-Small Cell Lung Cancer104 pag-aaral
- Metastatic Cancer53 pag-aaral
- Colorectal Cancer52 pag-aaral
- Kanser (lahat ng uri)48 pag-aaral
- Kanser sa Suso47 pag-aaral
- Kanser sa Ovary46 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser ng Endometrium39 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg26 pag-aaral
- Small Cell Lung Cancer23 pag-aaral
- Kanser sa Tiyan20 pag-aaral
- Triple-Negative Breast Cancer20 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.